StressCovidV1, PubMed, Checkpoint, bibRecord, 000658

Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.

Identifieur interne : 000658 ( PubMed/Checkpoint ); précédent : 000657; suivant : 000659

Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.

Auteurs : Xun-Long Shi [République populaire de Chine] ; Zhi-Hui Shi ; Hai Huang ; Hong-Guang Zhu ; Pei Zhou ; Dianwen Ju

Source :

Inflammation [ 1573-2576 ] ; 2010.

RBID : pubmed:19957025

Descripteurs français

KwdFr :
- Animaux, Antioxydants (pharmacologie), Catalase (pharmacologie), Estimation de Kaplan-Meier, Femelle, Humains, Infections à Orthomyxoviridae (anatomopathologie), Infections à Orthomyxoviridae (mortalité), Infections à Orthomyxoviridae (traitement médicamenteux), Lignées consanguines de souris, Pneumopathie virale (anatomopathologie), Pneumopathie virale (mortalité), Pneumopathie virale (traitement médicamenteux), Poumon (anatomopathologie), Poumon (métabolisme), Protéines recombinantes (pharmacologie), Radical hydroxyle (métabolisme), Souris, Sous-type H1N1 du virus de la grippe A, Stress oxydatif (), Superoxydes (métabolisme).
MESH :
- anatomopathologie : Infections à Orthomyxoviridae, Pneumopathie virale, Poumon.
- mortalité : Infections à Orthomyxoviridae, Pneumopathie virale.
- métabolisme : Poumon, Radical hydroxyle, Superoxydes.
- pharmacologie : Antioxydants, Catalase, Protéines recombinantes.
- traitement médicamenteux : Infections à Orthomyxoviridae, Pneumopathie virale.
- Animaux, Estimation de Kaplan-Meier, Femelle, Humains, Lignées consanguines de souris, Souris, Sous-type H1N1 du virus de la grippe A, Stress oxydatif.

English descriptors

KwdEn :
- Animals, Antioxidants (pharmacology), Catalase (pharmacology), Female, Humans, Hydroxyl Radical (metabolism), Influenza A Virus, H1N1 Subtype, Kaplan-Meier Estimate, Lung (metabolism), Lung (pathology), Mice, Mice, Inbred Strains, Orthomyxoviridae Infections (drug therapy), Orthomyxoviridae Infections (mortality), Orthomyxoviridae Infections (pathology), Oxidative Stress (drug effects), Pneumonia, Viral (drug therapy), Pneumonia, Viral (mortality), Pneumonia, Viral (pathology), Recombinant Proteins (pharmacology), Superoxides (metabolism).
MESH :
- chemical , metabolism : Hydroxyl Radical, Superoxides.
- chemical , pharmacology : Antioxidants, Catalase, Recombinant Proteins.
- drug effects : Oxidative Stress.
- drug therapy : Orthomyxoviridae Infections, Pneumonia, Viral.
- metabolism : Lung.
- mortality : Orthomyxoviridae Infections, Pneumonia, Viral.
- pathology : Lung, Orthomyxoviridae Infections, Pneumonia, Viral.
- Animals, Female, Humans, Influenza A Virus, H1N1 Subtype, Kaplan-Meier Estimate, Mice, Mice, Inbred Strains.

Abstract

Reactive oxygen species (ROS) are believed to play a key role in the induction of lung damage caused by pneumonia and therapeutic agents that could effectively scavenge ROS may prevent or reduce the deleterious effects of influenza-induced pneumonia. In this study, we first demonstrated that human catalase could attenuate acute oxidative injury in lung tissues following influenza-induced pneumonia. Mice were infected with influenza virus H1N1 (FM1 strain) and treated with recombinant human catalase (50,000 U/kg) by inhalation. The survival time and survival rates of H1N1 induced pneumonia mice were increased by treatment with recombinant human catalase. Protective efficacy of catalase was also observed in lung histology, anti-oxidant parameters, pulmonary pathology and influenza viral titer in lungs in mice. These observations were associated with increased serum superoxide and hydroxyl radical anion scavenging capacities. This study strongly indicated that recombinant catalase might be a potential therapy for H1N1 influenza-induced pneumonia.

DOI: 10.1007/s10753-009-9170-y
PubMed: 19957025

Affiliations:

République populaire de Chine

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000723
to stream PubMed, to step Curation: 000720

Links to Exploration step

pubmed:19957025

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.</title>
<author><name sortKey="Shi, Xun Long" sort="Shi, Xun Long" uniqKey="Shi X" first="Xun-Long" last="Shi">Xun-Long Shi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shi, Zhi Hui" sort="Shi, Zhi Hui" uniqKey="Shi Z" first="Zhi-Hui" last="Shi">Zhi-Hui Shi</name>
</author>
<author><name sortKey="Huang, Hai" sort="Huang, Hai" uniqKey="Huang H" first="Hai" last="Huang">Hai Huang</name>
</author>
<author><name sortKey="Zhu, Hong Guang" sort="Zhu, Hong Guang" uniqKey="Zhu H" first="Hong-Guang" last="Zhu">Hong-Guang Zhu</name>
</author>
<author><name sortKey="Zhou, Pei" sort="Zhou, Pei" uniqKey="Zhou P" first="Pei" last="Zhou">Pei Zhou</name>
</author>
<author><name sortKey="Ju, Dianwen" sort="Ju, Dianwen" uniqKey="Ju D" first="Dianwen" last="Ju">Dianwen Ju</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:19957025</idno>
<idno type="pmid">19957025</idno>
<idno type="doi">10.1007/s10753-009-9170-y</idno>
<idno type="wicri:Area/PubMed/Corpus">000723</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000723</idno>
<idno type="wicri:Area/PubMed/Curation">000720</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000720</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000658</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000658</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.</title>
<author><name sortKey="Shi, Xun Long" sort="Shi, Xun Long" uniqKey="Shi X" first="Xun-Long" last="Shi">Xun-Long Shi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shi, Zhi Hui" sort="Shi, Zhi Hui" uniqKey="Shi Z" first="Zhi-Hui" last="Shi">Zhi-Hui Shi</name>
</author>
<author><name sortKey="Huang, Hai" sort="Huang, Hai" uniqKey="Huang H" first="Hai" last="Huang">Hai Huang</name>
</author>
<author><name sortKey="Zhu, Hong Guang" sort="Zhu, Hong Guang" uniqKey="Zhu H" first="Hong-Guang" last="Zhu">Hong-Guang Zhu</name>
</author>
<author><name sortKey="Zhou, Pei" sort="Zhou, Pei" uniqKey="Zhou P" first="Pei" last="Zhou">Pei Zhou</name>
</author>
<author><name sortKey="Ju, Dianwen" sort="Ju, Dianwen" uniqKey="Ju D" first="Dianwen" last="Ju">Dianwen Ju</name>
</author>
</analytic>
<series><title level="j">Inflammation</title>
<idno type="eISSN">1573-2576</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antioxidants (pharmacology)</term>
<term>Catalase (pharmacology)</term>
<term>Female</term>
<term>Humans</term>
<term>Hydroxyl Radical (metabolism)</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Kaplan-Meier Estimate</term>
<term>Lung (metabolism)</term>
<term>Lung (pathology)</term>
<term>Mice</term>
<term>Mice, Inbred Strains</term>
<term>Orthomyxoviridae Infections (drug therapy)</term>
<term>Orthomyxoviridae Infections (mortality)</term>
<term>Orthomyxoviridae Infections (pathology)</term>
<term>Oxidative Stress (drug effects)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pneumonia, Viral (pathology)</term>
<term>Recombinant Proteins (pharmacology)</term>
<term>Superoxides (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antioxydants (pharmacologie)</term>
<term>Catalase (pharmacologie)</term>
<term>Estimation de Kaplan-Meier</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à Orthomyxoviridae (anatomopathologie)</term>
<term>Infections à Orthomyxoviridae (mortalité)</term>
<term>Infections à Orthomyxoviridae (traitement médicamenteux)</term>
<term>Lignées consanguines de souris</term>
<term>Pneumopathie virale (anatomopathologie)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Poumon (anatomopathologie)</term>
<term>Poumon (métabolisme)</term>
<term>Protéines recombinantes (pharmacologie)</term>
<term>Radical hydroxyle (métabolisme)</term>
<term>Souris</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Stress oxydatif ()</term>
<term>Superoxydes (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hydroxyl Radical</term>
<term>Superoxides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antioxidants</term>
<term>Catalase</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
<term>Pneumopathie virale</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Orthomyxoviridae Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Orthomyxoviridae Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Poumon</term>
<term>Radical hydroxyle</term>
<term>Superoxydes</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term>
<term>Orthomyxoviridae Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antioxydants</term>
<term>Catalase</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à Orthomyxoviridae</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Female</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Kaplan-Meier Estimate</term>
<term>Mice</term>
<term>Mice, Inbred Strains</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Estimation de Kaplan-Meier</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignées consanguines de souris</term>
<term>Souris</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Stress oxydatif</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Reactive oxygen species (ROS) are believed to play a key role in the induction of lung damage caused by pneumonia and therapeutic agents that could effectively scavenge ROS may prevent or reduce the deleterious effects of influenza-induced pneumonia. In this study, we first demonstrated that human catalase could attenuate acute oxidative injury in lung tissues following influenza-induced pneumonia. Mice were infected with influenza virus H1N1 (FM1 strain) and treated with recombinant human catalase (50,000 U/kg) by inhalation. The survival time and survival rates of H1N1 induced pneumonia mice were increased by treatment with recombinant human catalase. Protective efficacy of catalase was also observed in lung histology, anti-oxidant parameters, pulmonary pathology and influenza viral titer in lungs in mice. These observations were associated with increased serum superoxide and hydroxyl radical anion scavenging capacities. This study strongly indicated that recombinant catalase might be a potential therapy for H1N1 influenza-induced pneumonia.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19957025</PMID>
<DateCompleted><Year>2010</Year>
<Month>07</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-2576</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>33</Volume>
<Issue>3</Issue>
<PubDate><Year>2010</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Inflammation</Title>
<ISOAbbreviation>Inflammation</ISOAbbreviation>
</Journal>
<ArticleTitle>Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.</ArticleTitle>
<Pagination><MedlinePgn>166-72</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10753-009-9170-y</ELocationID>
<Abstract><AbstractText>Reactive oxygen species (ROS) are believed to play a key role in the induction of lung damage caused by pneumonia and therapeutic agents that could effectively scavenge ROS may prevent or reduce the deleterious effects of influenza-induced pneumonia. In this study, we first demonstrated that human catalase could attenuate acute oxidative injury in lung tissues following influenza-induced pneumonia. Mice were infected with influenza virus H1N1 (FM1 strain) and treated with recombinant human catalase (50,000 U/kg) by inhalation. The survival time and survival rates of H1N1 induced pneumonia mice were increased by treatment with recombinant human catalase. Protective efficacy of catalase was also observed in lung histology, anti-oxidant parameters, pulmonary pathology and influenza viral titer in lungs in mice. These observations were associated with increased serum superoxide and hydroxyl radical anion scavenging capacities. This study strongly indicated that recombinant catalase might be a potential therapy for H1N1 influenza-induced pneumonia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName>
<ForeName>Xun-long</ForeName>
<Initials>XL</Initials>
<AffiliationInfo><Affiliation>Department of Biosynthesis, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shi</LastName>
<ForeName>Zhi-hui</ForeName>
<Initials>ZH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Hai</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhu</LastName>
<ForeName>Hong-guang</ForeName>
<Initials>HG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhou</LastName>
<ForeName>Pei</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ju</LastName>
<ForeName>Dianwen</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Inflammation</MedlineTA>
<NlmUniqueID>7600105</NlmUniqueID>
<ISSNLinking>0360-3997</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>11062-77-4</RegistryNumber>
<NameOfSubstance UI="D013481">Superoxides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3352-57-6</RegistryNumber>
<NameOfSubstance UI="D017665">Hydroxyl Radical</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.11.1.6</RegistryNumber>
<NameOfSubstance UI="D002374">Catalase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002374" MajorTopicYN="N">Catalase</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017665" MajorTopicYN="N">Hydroxyl Radical</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013481" MajorTopicYN="N">Superoxides</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19957025</ArticleId>
<ArticleId IdType="doi">10.1007/s10753-009-9170-y</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Control Release. 2007 Aug 16;121(1-2):74-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17610981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2008 Apr 18;133(2):235-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18423196</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Pathol. 2008;3:499-522</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18039138</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Drug Deliv Rev. 2009 Apr 28;61(4):351-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19233238</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2009 Jun 12;137(6):983-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19524497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2009 Jul;45(3):174-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19540156</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Expr Purif. 2007 Jul;54(1):24-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17408968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2008 Nov;153(2):218-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18652846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Jun 19;324(5934):1557-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19433588</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Immunol. 2008 Aug;128(2):117-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18625437</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2009 Apr;1795(2):83-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19121370</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Wkly Epidemiol Rec. 2009 Sep 4;84(36):361-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19764123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Drug Deliv Rev. 2009 Apr 28;61(4):319-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19385054</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2007 Dec 17;25(52):8664-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18031873</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2009 Oct 1;47(7):941-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19577641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2006 Jun 1;40(11):1949-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16716896</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2009 Mar;81(3):253-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19135483</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biochem. 2009 Aug 1;107(5):933-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19459161</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2007 May 1;42(9):1338-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17395007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Lett. 2009 Sep 18;282(2):125-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19185987</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ecotoxicol Environ Saf. 2009 Jan;72(1):136-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18304632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2009 Jun 15;46(12 ):1658-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19341793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Atherosclerosis. 2007 Jul;193(1):28-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16973170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Cancer Res. 2004 Nov 15;10(22):7685-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15570002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Reprod Toxicol. 2009 Sep;28(2):167-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19379805</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Control Release. 2009 Apr 2;135(1):60-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19162102</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Pharmacol. 2009 Feb 1;77(3):285-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18948086</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Huang, Hai" sort="Huang, Hai" uniqKey="Huang H" first="Hai" last="Huang">Hai Huang</name>
<name sortKey="Ju, Dianwen" sort="Ju, Dianwen" uniqKey="Ju D" first="Dianwen" last="Ju">Dianwen Ju</name>
<name sortKey="Shi, Zhi Hui" sort="Shi, Zhi Hui" uniqKey="Shi Z" first="Zhi-Hui" last="Shi">Zhi-Hui Shi</name>
<name sortKey="Zhou, Pei" sort="Zhou, Pei" uniqKey="Zhou P" first="Pei" last="Zhou">Pei Zhou</name>
<name sortKey="Zhu, Hong Guang" sort="Zhu, Hong Guang" uniqKey="Zhu H" first="Hong-Guang" last="Zhu">Hong-Guang Zhu</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Shi, Xun Long" sort="Shi, Xun Long" uniqKey="Shi X" first="Xun-Long" last="Shi">Xun-Long Shi</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000658 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000658 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:19957025
   |texte=   Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:19957025" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021

	Serveur d'exploration Stress et Covid
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Stress et Covid

Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.

Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki